Skip to content

Public FDA record

Z-1440-2017: Eclipse Hypodermic Needle

Recall record Z-1440-2017 for Becton Dickinson & Company. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-1440-2017
Company in FDA record
Becton Dickinson & Company
FDA record creation date
Oct 11, 2018
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

BD is initiating a Product Advisory for the Eclipse Hypodermic Needle because of safety complaints covering disengagement and needlestick injuries.

Source facts

Action
BD sent a Product Advisory Notice and Business Reply Card dated December 29, 2016 via UPS Ground delivery to their affected customers.
Initiated
2016-12-20
Root cause
Device Design
Terminated
2018-04-20
Distribution
US Nationwide
Recall number
Z-1440-2017
Recall status
Terminated
CDRH record ID
152300
FDA record created
2018-10-11
Recall event number
76129

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗